Orlando, L., Lorusso, V., Giotta, F., Di Maio, M., Schiavone, P., Fedele, P., . . . Cinieri, S. (2020). Metronomic oral chemotherapy with cyclophosphamide plus capecitabine combined with trastuzumab (HEX) as first line therapy of HER-2 positive advanced breast cancer: A phase II trial of the Gruppo Oncologico Italia Meridionale (GOIM). Breast.
Chicago Style CitationOrlando, Laura, et al. "Metronomic Oral Chemotherapy With Cyclophosphamide Plus Capecitabine Combined With Trastuzumab (HEX) As First Line Therapy of HER-2 Positive Advanced Breast Cancer: A Phase II Trial of the Gruppo Oncologico Italia Meridionale (GOIM)." Breast 2020.
Cita MLAOrlando, Laura, et al. "Metronomic Oral Chemotherapy With Cyclophosphamide Plus Capecitabine Combined With Trastuzumab (HEX) As First Line Therapy of HER-2 Positive Advanced Breast Cancer: A Phase II Trial of the Gruppo Oncologico Italia Meridionale (GOIM)." Breast 2020.